missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human LGI2 Synthetic Peptide
Synthetic Peptide
Brand: Invitrogen™ PEP0613
This item is not returnable.
View return policy
Description
LGI2 Synthetic Peptide, PEP-0613, from Invitrogen.
The leucine-rich, glioma inactivated gene 2 (LGI2) is a member of the LGI family in which LGI1 is the exemplar. The LGI family consists of four of highly related proteins containing leucine-rich repeats (LRRs) which are highly similar to other transmembrane signaling molecules and receptors. LGI1 has been identified as a candidate tumor suppressor gene for glioma and plays a role in autodominant lateral temporal epilepsy (ADTLE), an epileptic syndrome characterized by focal seizures with predominant auditory symptoms. Despite its high homology with LGI1 and similar pattern of expression, mutations in LGI2 have not been found to be associated with ADTLE.
Specifications
| 55203 | |
| purified | |
| Human LGI2 | |
| -20°C | |
| Liquid | |
| Blocking Assay, Control | |
| No | |
| Peptide | |
| RUO - research use only |
| Human | |
| Q8N0V4 | |
| 200 μg/mL | |
| Synthetic Peptide | |
| PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 | |
| LGI2 | |
| 0.02% sodium azide | |
| 50 μg | |
| PBS |
Product Suggestions
Customers who viewed this item also viewed
Viewing 1-4 of
-
Catalog No. 10678484
kr 1 550,00 / 500mL -
Catalog No. 13464189
kr 800,00 / Pack of 5 -
Catalog No. 10647894
kr 2 145,00 / 250mL -
Catalog No. 11548876
kr 266,00 / 100mL -
Catalog No. 10729174
kr 2 425,00 / 500µL -
Catalog No. 15137105
kr 114 950,00 / Each -
Catalog No. 11514270
kr 6 970,00 / 100µL -
Catalog No. 15476929
kr 1 110,00 / 1mg
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Invitrogen™ Human LGI2 Synthetic Peptide > 50 μg; Unlabeled
Spot an opportunity for improvement?Share a Content Correction